A Phase I/Ib Trial of Pirfenidone Combined With Standard First-Line Chemotherapy in Advanced-Stage Lung NSCLC
Phase of Trial: Phase I
Latest Information Update: 27 Sep 2017
At a glance
- Drugs Pirfenidone (Primary) ; Carboplatin; Paclitaxel; Pemetrexed
- Indications Non-small cell lung cancer
- Focus Adverse reactions; Therapeutic Use
- 20 Sep 2017 Status changed from not yet recruiting to recruiting.
- 01 Aug 2017 Planned initiation date changed from 1 Oct 2017 to 1 Nov 2017.
- 27 Jun 2017 Planned initiation date changed from 1 Aug 2017 to 1 Oct 2017.